This liver cancer SIG program addresses the rapidly evolving surgical treatment options for HCC including resection and liver transplantation, which are making more patients with intermediate or even advanced stage disease potentially eligible for curative therapy. This session highlights the changing landscape of surgical options for HCC including identification and optimization of potential candidates for resection or transplant; advances in surgical techniques; the risk-benefit ratio of liver transplantation; and access to liver transplantation.